International Journal of Clinical Pediatric Dentistry

Register      Login

VOLUME 14 , ISSUE 4 ( July-August, 2021 ) > List of Articles


Glanzmann Thrombasthenia: Use of the Soft Splint with Tranexamic Acid Paste to Reduce Spontaneous Oral Bleeding

R Bhavyaa

Keywords : Glanzmann thrombasthenia, Oral bleeding, Soft splint, Tranexamic acid

Citation Information : Bhavyaa R. Glanzmann Thrombasthenia: Use of the Soft Splint with Tranexamic Acid Paste to Reduce Spontaneous Oral Bleeding. Int J Clin Pediatr Dent 2021; 14 (4):580-585.

DOI: 10.5005/jp-journals-10005-1973

License: CC BY-NC 4.0

Published Online: 29-10-2021

Copyright Statement:  Copyright © 2021; The Author(s).


Background: Glanzmann thrombasthenia is a rare bleeding disorder due to defects in the glycoprotein Ilb/IIIa complex present on the platelet membrane. The most common mode of treatment for this disorder is platelet transfusion. However, scientific evidence does state that repeated transfusions could lead to auto immunization making transfusions ineffective. Aim and objective: To describe the use of a novel technique of soft splint with tranexamic acid paste to stop oral bleeding in a patient with Glanzmann thrombasthenia (GT). Case description: A 7-year-old female patient with a known history of GT was referred to the pediatric department. The chief complaint of the patient revealed a history of spontaneous bleeding from the oral cavity. The patient required multiple teeth extractions due to severely carious teeth. History revealed that the patient was admitted to the hospital (casualty) three times within 1 month due to a similar complaint leading to hypovolemic shock. Several transfusion procedures were done to stop the spontaneous bleeding. To stop the intraoral bleeding without transfusions, a novel method of using a soft splint with tranexamic acid paste (500 mg tablet crushed and mixed with saline) in the area of spontaneous bleeding was employed with a successful follow-up of 7 months. Conclusion: Soft splint with the tranexamic acid paste can serve as an effective method of treatment for patients with spontaneous oral bleeding due to medical conditions like GT. Clinical relevance: This case report highlights the need for awareness among all the healthcare providers about the importance of regular dental visits. The healthcare providers also need to emphasize the same to all patients with medical conditions to avoid such life-threatening situations.

  1. Bisch FC, Bowen KJ, Hanson BS, et al. Dental considerations for a Glanzmann's thrombasthenia patient: case report. J Periodontol 1996;67(5):536–540. DOI: 10.1902/jop.1996.67.5.536.
  2. Venkat V, Kalluri S, Bandalore Hanumantha SR. Glanzmann's thrombasthenia – a rare case report of spontaneous gingival bleeding. J Indian Acad Oral Med Radiol 2018;30(1):88–91. DOI: 10.4103/jiaomr.jiaomr_43_17.
  3. Sebastiano C, Bromberg M, Breen K, et al. Glanzmann's thrombasthenia: report of a case and review of the literature. Int J Clin Exp Pathol 2010;3(4):443–447.
  4. Gopalakrishnan A, Veeraraghavan R, Panicker P. Hematological and surgical management in Glanzmann's thrombasthenia: a case report. J Indian Soc Pedod Prev Dent 2014;32(2):181–184. DOI: 10.4103/0970-4388.131000.
  5. Kantarci A, Cebeci I, Firatli E, et al. Periodontal management of Glanzmann's thrombasthenia: report of 3 cases. J Periodontol 1996;67(8):816–820. DOI: 10.1902/jop.1996.67.8.816.
  6. Yadalam U, Kranti K, Seshan H. Periodontal considerations for Glanzmann's thrombasthenic patient. J Indian Soc Periodontol 2008;12(1):26–27. DOI: 10.4103/0972-124X.44095.
  7. Franco R, Miranda M, Di Renzo L, et al. Glanzmann's thrombastenia: the role of tranexamic acid in oral surgery. Case Rep Dent 2018;2018:9370212. DOI: 10.1155/2018/9370212.
  8. Nurden AT. Glanzmann thrombasthenia. Orphanet J Rare Dis 2006;1(1):10. DOI: 10.1186/1750-1172-1-10.
  9. George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 1990;75(7):1383–1395. DOI: 10.1182/blood.V75.7.1383.1383.
  10. Bellucci S, Devergie A, Gluckman E, et al. Complete correction of Glanzmann's thrombasthenia by allogeneic bone-marrow transplantation. Br J Haematol 1985;59(4):635–641. DOI: 10.1111/j.1365-2141.1985.tb07358.x.
  11. Ishaqi MK, El-Hayek M, Gassas A, et al. Allogeneic stem cell transplantation for Glanzmann thrombasthenia. Pediatr Blood Cancer 2009;52(5):682–683. DOI: 10.1002/pbc.21888.
  12. Varkey I, Rai K, Hegde AM, et al. Clinical management of Glanzmann's thrombasthenia: a case report. J Dent (Tehran) 2014;11(2):242–247.
  13. Ogston D. Current status of antifibrinolytic drugs. Blood Rev 1989;3(1):1–4. DOI: 10.1016/0268-960x(89)90019-2.
  14. Lethagen S, Nilsson IM. DDAVP-induced enhancement of platelet retention: its dependence on platelet-von Willebrand factor and the platelet receptor GP IIb/IIIa. Eur J Haematol 1992;49(1):7–13. DOI: 10.1111/j.1600-0609.1992.tb00906.x.
  15. Okamoto S, Hijikata-Okunomiya A, Wanaka K, et al. Enzyme-controlling medicines: introduction. Semin Thromb Hemost 1997;23(6):493–501. DOI: 10.1055/s-2007-996127.
  16. Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med 2007;356(22):2301–2311. DOI: 10.1056/NEJMra067742.
  17. Nuvvula S, Gaddam KR, Kamatham R. Efficacy of tranexamic acid mouthwash as an alternative for factor replacement in gingival bleeding during dental scaling in cases of hemophilia: a randomized clinical trial. Contemp Clin Dent 2014;5(1):49–53. DOI: 10.4103/0976-237X.128663.
  18. Coetzee MJ. The use of topical crushed tranexamic acid tablets to control bleeding after dental surgery and from skin ulcers in haemophilia. Haemophilia 2007;13(4):443–444. DOI: 10.1111/j.1365-2516.2007.01479.x.
  19. Perkin RF, White GC, Webster WP. Glanzmann's thrombasthenia. Report of two oral surgical cases using a new microfibrillar collagen preparation and EACA for hemostasis. Oral Surg Oral Med Oral Pathol 1979;47(1):36–39. DOI: 10.1016/0030-4220(79)90098-7.
  20. Wood N. Management of extractions in a case of Glanzmann's disease. Br J Oral Surg 1973;11(2):152–154. DOI: 10.1016/0007-117x(73)90034-6.
  21. Mehta DN, Bhatia R. Dental considerations in the management of Glanzmann's thrombasthenia. Int J Clin Pediatr Dent 2010;3(1):51–56. DOI: 10.5005/jp-journals-10005-1054.
  22. Sugimura M, Yoshioka A, Morishita M, et al. Tooth extraction in a patient with Glanzmann's thrombasthenia. Int J Oral Surg 1975;4(3):130–135. DOI: 10.1016/s0300-9785(75)80005-6.
  23. Devan K, Peedikayil FC, Dhanesh N. Dental management of Glanzmann's thrombasthenia patient: a case report. Int J Med Health Res 2018;4(9):131–133.
  24. Murphy MF, Waters AH. Immunological aspects of platelet transfusions. Br J Haematol 1985;60(3):409–414. DOI: 10.1111/j.1365-2141.1985.tb07437.x.
  25. Levy-Toledano S, Tobelem G, Legrand C, et al. Acquired IgG antibody occurring in a thrombasthenic patient: its effect on human platelet function. Blood 1978;51(6):1065–1071. DOI: 10.1182/blood.V51.6.1065.1065.
  26. Newman PJ. Platelet GPIIb-IIIa: molecular variations and alloantigens. Thromb Haemost 1991;66(1):111–118. DOI: 10.1055/s-0038-1646378.
  27. Jennings LK, Wang WC, Jackson CW, et al. Hemostasis in Glanzmann's thrombasthenia (GT): GT platelets interfere with the aggregation of normal platelets. Am J Pediatr Hematol Oncol 1991;13(1):84–90. DOI: 10.1097/00043426-199121000-00018.
  28. Yamaguchi K, Kawakatsu T, Kido H, et al. Platelet transfusion for patients with Glanzmann's thromboasthenia. Vox Sang 1992;63(4):290. DOI: 10.1111/j.1423-0410.1992.tb01241.x.
  29. Ghosh A, Kumar S, Chacko R, et al. Total extraction as a treatment for anaemia in a patient of Glanzmann's thrombasthenia with chronic gingival bleed: case report. J Clin Diagn Res 2016;10(1):ZD11–ZD12. DOI: 10.7860/JCDR/2016/16383.7123.
  30. Pabinger I, Fries D, Schöchl H, et al. Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis. Wien Klin Wochenschr 2017;129(9-10):303–316. DOI: 10.1007/s00508-017-1194-y.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.